{\rtf1\ansi\deff0 
{\fonttbl {\f0\fmodern Courier New;}
{\colortbl;\red0\green0\blue0;}
}
\deflang1033\margl610\margr360\margt810\margb360\fs14\sl-180\slmult0\paperw12240\paperh15840
1                                           The SAS System            13:02 Tuesday, February 21, 2017
\par 
\par NOTE: Copyright (c) 2002-2012 by SAS Institute Inc., Cary, NC, USA.
\par NOTE: SAS (r) Proprietary Software 9.4 (TS1M2)
\par       Licensed to SOCIAL & SCIENTIFIC SYSTEMS INC/AHRQ4, Site 70109165.
\par NOTE: This session is executing on the X64_7PRO  platform.
\par 
\par 
\par 
\par NOTE: Updated analytical products:
\par 
\par       SAS/STAT 13.2
\par 
\par NOTE: Additional host information:
\par 
\par  X64_7PRO WIN 6.1.7601 Service Pack 1 Workstation
\par 
\par NOTE: SAS initialization used:
\par       real time           0.27 seconds
\par       cpu time            0.32 seconds
\par 
\par 
\par NOTE: AUTOEXEC processing beginning; file is \\\\source.ahrq.local\\source\\MEPS\\_PUFINFO\\autoexec.sas.
\par 
\par local directory autoexec processed
\par 
\par NOTE: AUTOEXEC processing completed.
\par 
\par 1          /*********************************************************************\\
\par 2
\par 3          PROGRAM: 	C:\\MEPS\\SAS\\PROG\\EXERCISE2.SAS
\par 4
\par 5          PURPOSE:	THIS PROGRAM GENERATES SELECTED ESTIMATES FOR A 2014 VERSION OF THE
\par 6                          MEPS STATISTICS BRIEF # 275: "Trends in Antipsychotics Purchases and Expenses for the U.S. Civilian
\par 7                                                        Noninstitutionalized Population, 1997 and 2007"
\par 8
\par 9              (1) FIGURE 1: TOTAL EXPENSE FOR ANTIPSYCHOTICS
\par 10
\par 11             (2) FIGURE 2: TOTAL NUMBER OF PURCHASES OF ANTIPSYCHOTICS
\par 12
\par 13             (3) FIGURE 3: TOTAL NUMBER OF PERSONS PURCHASING ONE OR MORE ANTIPSYCHOTICS
\par 14
\par 15             (4) FIGURE 4: AVERAGE TOTAL, OUT OF POCKET, AND THIRD PARTY PAYER EXPENSE
\par 16                           FOR ANTIPSYCHOTICS PER PERSON WITH AN ANTIPSYCHOTIC MEDICINE PURCHASE
\par 17
\par 18         INPUT FILES:  (1) C:\\MEPS\\SAS\\DATA\\H1171.SAS7BDAT (2014 FULL-YEAR CONSOLIDATED PUF)
\par 19                       (2) C:\\MEPS\\SAS\\DATA\\H168A.SAS7BDAT (2014 PRESCRIBED MEDICINES PUF)
\par 20
\par 21         \\*********************************************************************/
\par 22
\par 23         OPTIONS LS=132 PS=79 NODATE;
\par 24
\par 25         *LIBNAME CDATA 'C:\\MEPS\\SAS\\DATA';
\par 26         LIBNAME CDATA "\\\\programs.ahrq.local\\programs\\meps\\AHRQ4_CY2\\B_CFACT\\BJ001DVK\\Workshop_2017\\SAS\\Data";
\par NOTE: Libref CDATA was successfully assigned as follows:
\par       Engine:        V9
\par       Physical Name: \\\\programs.ahrq.local\\programs\\meps\\AHRQ4_CY2\\B_CFACT\\BJ001DVK\\Workshop_2017\\SAS\\Data
\par 27
\par 28         TITLE1 '2017 AHRQ MEPS DATA USERS WORKSHOP';
\par 29         TITLE2 "EXERCISE2.SAS: Antipsychotics Purchases and Expenses, 2014";
\par 30
\par 31         PROC FORMAT;
\par 32           VALUE GTZERO
\par 33              0         = '0'
\par 34              0 <- HIGH = '>0'
\par 35              ;
\par NOTE: Format GTZERO is already on the library WORK.FORMATS.
\par NOTE: Format GTZERO has been output.
\par 36         RUN;
\par 
\par NOTE: PROCEDURE FORMAT used (Total process time):
\par       real time           0.00 seconds
\par       cpu time            0.00 seconds
\par 
\par 
\par 37
\par 38         /*1) IDENTIFY ANTIPSYCHOTIC DRUGS USING THERAPEUTIC CLASSIFICATION (TC) CODES*/
\par 39
\par 40         DATA DRUG;
\par \page 2                                                          The SAS System
\par 
\par 41           SET CDATA.H168A;
\par 42           IF TC1=242 AND TC1S1=251; /*definition of ANTIPSYCHOTIC DRUGS*/
\par 43         RUN;
\par 
\par NOTE: There were 319467 observations read from the data set CDATA.H168A.
\par NOTE: The data set WORK.DRUG has 3547 observations and 69 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           8.65 seconds
\par       cpu time            1.07 seconds
\par 
\par 
\par 44
\par 45         TITLE3 "A SAMPLE DUMP FOR PMED RECORDS WITH ANTIPSYCHOTIC DRUGS";
\par 46         PROC PRINT DATA=DRUG (OBS=30);
\par 47         VAR RXRECIDX LINKIDX TC1 TC1S1 	RXXP14X RXSF14X;
\par 48          BY DUPERSID;
\par 49         RUN;
\par 
\par NOTE: There were 30 observations read from the data set WORK.DRUG.
\par NOTE: The PROCEDURE PRINT printed page 1.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par       real time           0.07 seconds
\par       cpu time            0.07 seconds
\par 
\par 
\par 50
\par 51
\par 52         /*2) SUM DATA TO PERSON-LEVEL*/
\par 53
\par 54         PROC SUMMARY DATA=DRUG NWAY;
\par 55           CLASS DUPERSID;
\par 56           VAR RXXP14X RXSF14X;
\par 57           OUTPUT OUT=PERDRUG (DROP=_TYPE_) sum=TOT OOP;
\par 58         RUN;
\par 
\par NOTE: Multiple concurrent threads will be used to summarize data.
\par NOTE: There were 3547 observations read from the data set WORK.DRUG.
\par NOTE: The data set WORK.PERDRUG has 454 observations and 4 variables.
\par NOTE: PROCEDURE SUMMARY used (Total process time):
\par       real time           0.03 seconds
\par       cpu time            0.03 seconds
\par 
\par 
\par 59
\par 60         TITLE3 "A SAMPLE DUMP FOR PERSON-LEVEL EXPENDITURES FOR ANTIPSYCHOTIC DRUGS";
\par 61         PROC PRINT DATA=PERDRUG (OBS=30);
\par 62         RUN;
\par 
\par NOTE: There were 30 observations read from the data set WORK.PERDRUG.
\par NOTE: The PROCEDURE PRINT printed page 2.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par       real time           0.00 seconds
\par       cpu time            0.00 seconds
\par 
\par 
\par 63
\par 64         DATA PERDRUG2;
\par 65          SET PERDRUG;
\par 66              RENAME _FREQ_ = N_PHRCHASE ;
\par 67              THIRD_PAYER   = TOT - OOP;
\par 68         RUN;
\par 
\par NOTE: There were 454 observations read from the data set WORK.PERDRUG.
\par NOTE: The data set WORK.PERDRUG2 has 454 observations and 5 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           0.01 seconds
\par       cpu time            0.01 seconds
\par 
\par 
\par 69
\par 70         /*3) MERGE THE PERSON-LEVEL EXPENDITURES TO THE FY PUF*/
\par 71
\par 72         DATA  FY;
\par 73         MERGE CDATA.H171 (IN=AA KEEP=DUPERSID VARSTR VARPSU PERWT14F)
\par 74               PERDRUG2  (IN=BB KEEP=DUPERSID N_PHRCHASE TOT OOP THIRD_PAYER);
\par 75            BY DUPERSID;
\par 76
\par \page 3                                                          The SAS System
\par 
\par 77               IF AA AND BB THEN DO;
\par 78                  SUB      = 1 ;
\par 79               END;
\par 80
\par 81               ELSE IF NOT BB THEN DO;   /*FOR PERSONS WITHOUT ANY PURCHASE OF ANTIPSYCHOTIC DRUGS*/
\par 82                  SUB         = 2 ;
\par 83                  N_PHRCHASE  = 0 ;
\par 84                  THIRD_PAYER = 0 ;
\par 85                  TOT         = 0 ;
\par 86                  OOP         = 0 ;
\par 87               END;
\par 88
\par 89               IF AA;
\par 90
\par 91               LABEL
\par 92                     THIRD_PAYER = 'TOTAL-OOP'
\par 93                     N_PHRCHASE  = '# OF PURCHASES PER PERSON'
\par 94                     SUB         = 'POPULATION FLAG FOR PERSONS WITH 1+ ANTIPSYCHOTIC DRUGS'
\par 95                                 ;
\par 96         RUN;
\par 
\par NOTE: There were 34875 observations read from the data set CDATA.H171.
\par NOTE: There were 454 observations read from the data set WORK.PERDRUG2.
\par NOTE: The data set WORK.FY has 34875 observations and 9 variables.
\par NOTE: DATA statement used (Total process time):
\par       real time           5.03 seconds
\par       cpu time            1.49 seconds
\par 
\par 
\par 97
\par 98         TITLE3 "SUPPORTING CROSSTABS FOR NEW VARIABLES";
\par 99         PROC FREQ DATA=FY;
\par 100          TABLES  SUB * N_PHRCHASE * TOT * OOP * THIRD_PAYER / LIST MISSING ;
\par 101          FORMAT N_PHRCHASE TOT OOP THIRD_PAYER gtzero. ;
\par 102        RUN;
\par 
\par NOTE: There were 34875 observations read from the data set WORK.FY.
\par NOTE: The PROCEDURE FREQ printed page 3.
\par NOTE: PROCEDURE FREQ used (Total process time):
\par       real time           0.06 seconds
\par       cpu time            0.06 seconds
\par 
\par 
\par 103
\par 104
\par 105        /*4) CALCULATE ESTIMATES ON EXPENDITURES AND USE*/
\par 106
\par 107        ODS LISTING CLOSE;
\par 108        TITLE3 "PERSON-LEVEL ESTIMATES ON EXPENDITURES AND USE FOR ANTIPSYCHOTIC DRUGS, 2014";
\par 109        PROC SURVEYMEANS DATA=FY NOBS SUMWGT SUM STD MEAN STDERR;
\par 110          STRATA  VARSTR ;
\par 111          CLUSTER VARPSU;
\par 112          WEIGHT  PERWT14F;
\par 113          DOMAIN  SUB ;
\par 114          VAR TOT N_PHRCHASE  OOP THIRD_PAYER ;
\par 115          ODS OUTPUT DOMAIN=OUT1;
\par 116        RUN;
\par 
\par NOTE: Due to nonpositive weights, 1713 observation(s) were deleted.
\par NOTE: Only one cluster in a stratum in domain POPULATION FLAG FOR PERSONS WITH 1+ ANTIPSYCHOTIC DRUGS for variable(s) TOT,
\par       N_PHRCHASE, OOP, THIRD_PAYER. The estimate of variance for TOT, N_PHRCHASE, OOP, THIRD_PAYER will omit this stratum.
\par NOTE: The data set WORK.OUT1 has 8 observations and 10 variables.
\par NOTE: PROCEDURE SURVEYMEANS used (Total process time):
\par       real time           0.35 seconds
\par       cpu time            0.35 seconds
\par 
\par 
\par 117        ODS LISTING;
\par 118
\par 119        TITLE3 "RESULTS FROM PROC SURVEYMEANS WITH A DOMAIN STATEMENT";
\par 120        PROC PRINT DATA=OUT1 (DROP=DOMAINLABEL) NOOBS;
\par 121        FORMAT N COMMA6.0 SUMWGT SUM  STDDEV comma15.0 MEAN STDERR comma9.2  ;
\par 122        RUN;
\par 
\par NOTE: There were 8 observations read from the data set WORK.OUT1.
\par NOTE: The PROCEDURE PRINT printed page 4.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par \page 4                                                          The SAS System
\par 
\par       real time           0.00 seconds
\par       cpu time            0.00 seconds
\par 
\par 
\par 123
\par 124        TITLE4 "SUBSET THE ESTIMATES FOR PERSONS ONLY WITH 1+ ANTIPSYCHOTIC DRUGS";
\par 125        PROC PRINT DATA=OUT1 (WHERE=(SUB=1)) NOOBS;
\par 126        VAR VARNAME VARLABEL N SUMWGT SUM STDDEV MEAN STDERR;
\par 127        FORMAT N COMMA6.0 SUMWGT SUM  STDDEV comma15.0 MEAN STDERR comma9.2  ;
\par 128        RUN;
\par 
\par NOTE: There were 4 observations read from the data set WORK.OUT1.
\par       WHERE SUB=1;
\par NOTE: The PROCEDURE PRINT printed page 5.
\par NOTE: PROCEDURE PRINT used (Total process time):
\par       real time           0.00 seconds
\par       cpu time            0.00 seconds
\par 
\par 
\par NOTE: SAS Institute Inc., SAS Campus Drive, Cary, NC USA 27513-2414
\par NOTE: The SAS System used:
\par       real time           15.91 seconds
\par       cpu time            4.02 seconds
\par 
\par \page                                                  2017 AHRQ MEPS DATA USERS WORKSHOP                                                1
\par                                      EXERCISE2.SAS: Antipsychotics Purchases and Expenses, 2014
\par                                       A SAMPLE DUMP FOR PMED RECORDS WITH ANTIPSYCHOTIC DRUGS
\par 
\par ------------------------------------------------- PERSON ID (DUID + PID)=40097101 --------------------------------------------------
\par 
\par                             Obs       RXRECIDX          LINKIDX       TC1    TC1S1    RXXP14X    RXSF14X
\par 
\par                               1    400971010931001    400971010931    242     251      116.84     12.00
\par                               2    400971010931002    400971010931    242     251      149.11     12.00
\par                               3    400971010951001    400971010951    242     251       25.21     12.00
\par                               4    400971010951002    400971010951    242     251       25.71     12.00
\par                               5    400971010961001    400971010961    242     251        4.27      4.27
\par                               6    400971010961002    400971010961    242     251        3.00      3.00
\par                               7    400971011101001    400971011101    242     251      149.11     12.00
\par                               8    400971011101002    400971011101    242     251      166.58     12.00
\par                               9    400971011101003    400971011101    242     251      141.40     12.00
\par                              10    400971011101004    400971011101    242     251      139.76     12.00
\par                              11    400971011121001    400971011121    242     251       25.21     12.00
\par                              12    400971011121002    400971011121    242     251       25.21     12.00
\par                              13    400971011121003    400971011121    242     251       25.71     12.00
\par                              14    400971011121004    400971011121    242     251       25.71     12.00
\par                              15    400971011131001    400971011131    242     251        2.84      2.84
\par                              16    400971011131002    400971011131    242     251        3.76      3.76
\par                              17    400971011131003    400971011131    242     251        3.76      3.76
\par                              18    400971011131004    400971011131    242     251        3.76      3.76
\par                              19    400971011181001    400971011181    242     251      129.09     12.00
\par                              20    400971011181002    400971011181    242     251      127.34     12.00
\par                              21    400971011181003    400971011181    242     251      127.50     12.00
\par                              22    400971011201001    400971011201    242     251       25.21     12.00
\par                              23    400971011201002    400971011201    242     251       25.21     12.00
\par                              24    400971011201003    400971011201    242     251       25.71     12.00
\par                              25    400971011211001    400971011211    242     251        3.75      3.75
\par                              26    400971011211002    400971011211    242     251        3.75      3.75
\par                              27    400971011211003    400971011211    242     251        3.75      3.75
\par 
\par 
\par ------------------------------------------------- PERSON ID (DUID + PID)=40209101 --------------------------------------------------
\par 
\par                             Obs       RXRECIDX          LINKIDX       TC1    TC1S1    RXXP14X    RXSF14X
\par 
\par                              28    402091010121001    402091010121    242     251      998.99       0
\par 
\par 
\par ------------------------------------------------- PERSON ID (DUID + PID)=40224103 --------------------------------------------------
\par 
\par                             Obs       RXRECIDX          LINKIDX       TC1    TC1S1    RXXP14X    RXSF14X
\par 
\par                              29    402241030181001    402241030181    242     251        10         10
\par                              30    402241030181002    402241030181    242     251        10         10
\par \page                                                  2017 AHRQ MEPS DATA USERS WORKSHOP                                                2
\par                                      EXERCISE2.SAS: Antipsychotics Purchases and Expenses, 2014
\par                                 A SAMPLE DUMP FOR PERSON-LEVEL EXPENDITURES FOR ANTIPSYCHOTIC DRUGS
\par 
\par                                           Obs    DUPERSID    _FREQ_         TOT       OOP
\par 
\par                                             1    40097101      27       1508.26    248.64
\par                                             2    40209101       1        998.99      0.00
\par                                             3    40224103       2         20.00     20.00
\par                                             4    40296102      10       4955.78      0.00
\par                                             5    40333103      36      14561.24    600.00
\par                                             6    40338102       1        791.67      0.00
\par                                             7    40342101       1          8.53      0.00
\par                                             8    40384102       4         81.40      4.00
\par                                             9    40481102       4         39.31     39.31
\par                                            10    40515103      12       6737.38      0.00
\par                                            11    40605101       7       7632.63     25.40
\par                                            12    40606101       2       1784.27     30.00
\par                                            13    40618102       7         57.88     54.34
\par                                            14    40652101       3        117.90    117.90
\par                                            15    40669102       7         77.81     51.64
\par                                            16    40673101       5      21875.25      0.00
\par                                            17    40736101       2       5258.85     40.00
\par                                            18    40769101      13         91.13     91.13
\par                                            19    40789101       1         12.29      5.00
\par                                            20    40789103      10       8199.90     35.27
\par                                            21    40802102      12        456.12     18.00
\par                                            22    40825101      10        232.40      2.40
\par                                            23    40862101      22       1101.08     16.80
\par                                            24    41017101       1          4.10      0.00
\par                                            25    41032103      20      16558.16    390.00
\par                                            26    41034104       6       5993.94      0.00
\par                                            27    41043101      13         78.00     78.00
\par                                            28    41051101       8       2724.29     80.00
\par                                            29    41113101       8       2310.00     20.40
\par                                            30    41130101       7        130.04     47.65
\par \page                                                  2017 AHRQ MEPS DATA USERS WORKSHOP                                                3
\par                                      EXERCISE2.SAS: Antipsychotics Purchases and Expenses, 2014
\par                                                SUPPORTING CROSSTABS FOR NEW VARIABLES
\par 
\par                                                          The FREQ Procedure
\par 
\par                                                                                            Cumulative    Cumulative
\par                 SUB    N_PHRCHASE    TOT    OOP    THIRD_PAYER    Frequency     Percent     Frequency      Percent
\par                 ---------------------------------------------------------------------------------------------------
\par                   1    >0            0      0      0                     1        0.00             1         0.00
\par                   1    >0            >0     0      >0                  127        0.36           128         0.37
\par                   1    >0            >0     >0     0                    45        0.13           173         0.50
\par                   1    >0            >0     >0     >0                  281        0.81           454         1.30
\par                   2    0             0      0      0                 34421       98.70         34875       100.00
\par \page                                                  2017 AHRQ MEPS DATA USERS WORKSHOP                                                4
\par                                      EXERCISE2.SAS: Antipsychotics Purchases and Expenses, 2014
\par                                        RESULTS FROM PROC SURVEYMEANS WITH A DOMAIN STATEMENT
\par 
\par SUB VARNAME     VARLABEL                                      N          SUMWGT             SUM          STDDEV      MEAN    STDERR
\par 
\par  1  TOT         SUM OF PAYMENTS RXSF14X-RXOU14X(IMPUTED)    445       4,478,820  11,895,377,978   1,156,964,813  2,655.92    202.57
\par  1  N_PHRCHASE  # OF PURCHASES PER PERSON                   445       4,478,820      34,695,151       2,737,619      7.75      0.37
\par  1  OOP         AMOUNT PAID, SELF OR FAMILY (IMPUTED)       445       4,478,820     909,418,096     310,456,107    203.05     70.93
\par  1  THIRD_PAYER TOTAL-OOP                                   445       4,478,820  10,985,959,882   1,180,157,602  2,452.87    207.28
\par  2  TOT         SUM OF PAYMENTS RXSF14X-RXOU14X(IMPUTED) 32,717     313,961,603               0               0      0.00      0.00
\par  2  N_PHRCHASE  # OF PURCHASES PER PERSON                32,717     313,961,603               0               0      0.00      0.00
\par  2  OOP         AMOUNT PAID, SELF OR FAMILY (IMPUTED)    32,717     313,961,603               0               0      0.00      0.00
\par  2  THIRD_PAYER TOTAL-OOP                                32,717     313,961,603               0               0      0.00      0.00
\par \page                                                  2017 AHRQ MEPS DATA USERS WORKSHOP                                                5
\par                                      EXERCISE2.SAS: Antipsychotics Purchases and Expenses, 2014
\par                                        RESULTS FROM PROC SURVEYMEANS WITH A DOMAIN STATEMENT
\par                                  SUBSET THE ESTIMATES FOR PERSONS ONLY WITH 1+ ANTIPSYCHOTIC DRUGS
\par 
\par   VARNAME     VARLABEL                                      N          SUMWGT             SUM          STDDEV      MEAN    STDERR
\par 
\par   TOT         SUM OF PAYMENTS RXSF14X-RXOU14X(IMPUTED)    445       4,478,820  11,895,377,978   1,156,964,813  2,655.92    202.57
\par   N_PHRCHASE  # OF PURCHASES PER PERSON                   445       4,478,820      34,695,151       2,737,619      7.75      0.37
\par   OOP         AMOUNT PAID, SELF OR FAMILY (IMPUTED)       445       4,478,820     909,418,096     310,456,107    203.05     70.93
\par   THIRD_PAYER TOTAL-OOP                                   445       4,478,820  10,985,959,882   1,180,157,602  2,452.87    207.28
}
